TC BIOPHARM HOLDINGS PLC's ticker is and the CUSIP is 87807D111. A total of 6 filers reported holding TC BIOPHARM HOLDINGS PLC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $787 | -51.4% | 37,647 | 0.0% | 0.00% | – |
| Q2 2023 | $1,619 | -57.0% | 37,647 | -0.0% | 0.00% | – |
| Q1 2023 | $3,761 | -28.6% | 37,648 | +0.0% | 0.00% | – |
| Q4 2022 | $5,271 | -98.8% | 37,647 | -98.0% | 0.00% | -100.0% |
| Q3 2022 | $435,000 | +14.2% | 1,882,352 | 0.0% | 0.01% | +14.3% |
| Q2 2022 | $381,000 | -58.7% | 1,882,352 | 0.0% | 0.01% | -61.1% |
| Q1 2022 | $922,000 | – | 1,882,352 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nantahala Capital Management | 235,294 | $23,506 | 0.00% |
| Altium Capital Management LP | 18,823 | $1,880 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 14,174 | $1,410 | 0.00% |
| ARMISTICE CAPITAL, LLC | 37,648 | $3,761 | 0.00% |
| UBS Group AG | 200 | $20 | 0.00% |